{"id":"immediate-release-torsemide","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Hypokalemia"},{"rate":"5-10%","effect":"Hyponatremia"},{"rate":"5-10%","effect":"Dehydration"}]},"_chembl":{"chemblId":"CHEMBL1148","moleculeType":"Small molecule","molecularWeight":"348.43"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This leads to increased sodium and water excretion, resulting in a diuretic effect.","oneSentence":"Inhibits the sodium-chloride cotransporter in the distal convoluted tubule of the kidneys.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:35:29.905Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Edema"},{"name":"Hypertension"}]},"trialDetails":[{"nctId":"NCT06206512","phase":"PHASE2","title":"Effect of Extended Release Torsemide in Patients With Congestive Heart Failure and Overactive Bladder","status":"COMPLETED","sponsor":"Sarfez Pharmaceuticals, Inc.","startDate":"2024-06-15","conditions":"Heart Failure, Overactive Bladder, Incontinence","enrollment":24},{"nctId":"NCT06995144","phase":"PHASE4","title":"Comparing Natriuretic Effects of ER Torsemide to IR Torsemide in Patients With Heart Failure","status":"COMPLETED","sponsor":"Sarfez Pharmaceuticals, Inc.","startDate":"2025-05-28","conditions":"Heart Failure, Edema, Pulmonary Congestion","enrollment":20},{"nctId":"NCT07015671","phase":"PHASE3","title":"Bioavailability and Bioequivalence Study of ER Torsemide and Spironolactone FDC Tablet in Healthy Subjects","status":"COMPLETED","sponsor":"Sarfez Pharmaceuticals, Inc.","startDate":"2025-07-01","conditions":"Bioequivalence Study in Healthy Subjects, PK/PD","enrollment":24},{"nctId":"NCT06708611","phase":"PHASE4","title":"A Crossover Study of Patients with HF to Compare Natriuretic Effects of IR Torsemide Vs. ER Torsemide Over 12 Hrs","status":"TERMINATED","sponsor":"Sarfez Pharmaceuticals, Inc.","startDate":"2025-01-15","conditions":"Heart Failure","enrollment":5},{"nctId":"NCT06176794","phase":"PHASE2","title":"Immediate Release Torsemide Versus Extended Release Torsemide After Salty Meal","status":"TERMINATED","sponsor":"Sarfez Pharmaceuticals, Inc.","startDate":"2024-11-15","conditions":"Heart Failure","enrollment":1},{"nctId":"NCT03214874","phase":"PHASE1","title":"Within Subject Variability Study of ER Torsemide 20 mg Tablet in Healthy Subjects","status":"COMPLETED","sponsor":"Sarfez Pharmaceuticals, Inc.","startDate":"2017-06-19","conditions":"Congestive Heart Failure, Chronic Kidney Diseases","enrollment":24},{"nctId":"NCT00334386","phase":"PHASE4","title":"Hypertension Study: Multinational Torasemide Trial in Mild to Moderate Hypertension.","status":"COMPLETED","sponsor":"Ferrer Internacional S.A.","startDate":"2005-04","conditions":"Hypertension","enrollment":388}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Immediate release torsemide","genericName":"Immediate release torsemide","companyName":"Sarfez Pharmaceuticals, Inc.","companyId":"sarfez-pharmaceuticals-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Immediate release torsemide is a small molecule that inhibits the sodium-(potassium)-chloride cotransporter 2, which is a target of the solute carrier family 12 member 1. It is used to treat conditions such as congestive heart failure, chronic kidney diseases, hypertension, heart failure, and edema, as indicated by ClinicalTrials.gov.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}